Bretylium


- TRADE NAMES: Bretylate; Critifib
- INDICATIONS: Ventricular tachycardia and fibrillation
- CLASS: Antiarrhythmic class III
- HALF-LIFE: 4–17 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Arsenic, Astemizole, Ciprofloxacin, Enoxacin, Gatifloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Quinolones, Sparfloxacin
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
OTHER.
Page last updated 09/03/2019
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric